Cargando…

Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important

Detalles Bibliográficos
Autor principal:	Markopoulos, Christos
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949639/ https://www.ncbi.nlm.nih.gov/pubmed/20727234 http://dx.doi.org/10.1186/bcr2609

Ejemplares similares

Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
por: Sakaguchi, Koichi, et al.
Publicado: (2019)

Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
por: Van Poznak, Catherine
Publicado: (2010)

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
por: de Sire, Alessandro, et al.
Publicado: (2022)

Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study
por: Nakatsukasa, Katsuhiko, et al.
Publicado: (2018)

Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density
por: Nunes, Frederico Arthur Pereira, et al.
Publicado: (2021)

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Are another 5 years of adjuvant aromatase inhibitor therapy needed?
por: Mo, Qin-Guo, et al.
Publicado: (2016)

Bone Mineral Density and Qigong Training in Breast Cancer Survivors
por: Moran, Jose-María, et al.
Publicado: (2019)

Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?
por: Safaei-Nodehi, Reza, et al.
Publicado: (2017)

Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
por: Chen, Han, et al.
Publicado: (2020)

Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
por: Kwan, Marilyn L., et al.
Publicado: (2014)

Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
por: Kamimura, Mikio, et al.
Publicado: (2018)

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis
por: Chen, Shanshan, et al.
Publicado: (2022)

Is there a positive association between mammographic density and bone mineral density?
por: Dite, Gillian S, et al.
Publicado: (2006)

Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer
por: Christensen, Carina Ørts, et al.
Publicado: (2016)

Measurement of Bone Mineral Density in Children With Cancer
por: Barr, Ronald D.
Publicado: (2013)

Bone mineral density loss in patients with cirrhosis
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2019)

Prevalence and patterns of bone mineral density disorders among women in Buraidah, KSA
por: Al-Mendalawi, Mahmood D.
Publicado: (2023)

From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors
por: Vasconcelos de Matos, Leonor, et al.
Publicado: (2021)

Assessment of bone health in breast cancer patients starting adjuvant aromatase inhibitors: A quality improvement clinical audit
por: Zekri, Jamal, et al.
Publicado: (2016)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Will the bone mineral density in postmenopausal women get worse during the COVID-19 pandemic?
por: Cheng, Yunzhong, et al.
Publicado: (2022)

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial
por: Markopoulos, Christos, et al.
Publicado: (2012)

Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015)

Peak bone mineral density in Vietnamese women
por: Nguyen, H. T. T., et al.
Publicado: (2009)

Bone mineral density in healthy Kuwaiti women
por: Mahussain, S., et al.
Publicado: (2006)

Is there a positive association between mammographic density and bone mineral density? Authors' response
por: Crandall, Carolyn, et al.
Publicado: (2006)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
por: Sun, Shengliang, et al.
Publicado: (2016)

Conversion of measured bone mineral density T-scores of Chinese women to equivalent Caucasian women’s T-score values
por: Xiao, Ben-Heng, et al.
Publicado: (2023)

The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer
por: Inoue, Hiroaki, et al.
Publicado: (2015)

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health
por: Erbağ, Gökhan, et al.
Publicado: (2015)

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.
por: Saarto, T., et al.
Publicado: (1997)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Anastrozole (Arimidex ™) – an aromatase inhibitor for the adjuvant setting?
por: Buzdar, A U
Publicado: (2001)

Bone mineral density and reference standards for Indian women
por: Vaidya, Rama, et al.
Publicado: (2010)

Bone mineral density in women above 40 years
por: Unni, Jyothi, et al.
Publicado: (2010)

Bone mineral density in women with polycystic ovary syndrome
por: Katulski, K., et al.
Publicado: (2014)

Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
por: Bojanić, Kristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nhimc7p4t9uvr8bns887diards